SBI Securities
COGT icon

SBI Securities’s Cogent Biosciences COGT Stock Holding History

SBI Securities’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$32 Hold
1
– – ﹤0.01% 3835
2026
Q2 		$39 Hold
1
– – ﹤0.01% 3723
2026
Q1 		$38 Hold
1
– – ﹤0.01% 3629
2025
Q4 		$36 Sell
1
-93
-99% -$2.61K ﹤0.01% 3644
2025
Q3 		$1.35K Buy
94
+1
+1% +$12 ﹤0.01% 2574
2025
Q2 		$668 Hold
93
– – ﹤0.01% 2846
2025
Q1 		$557 Hold
93
– – ﹤0.01% 2826
2024
Q4 		$725 Buy
+93
New +$927 ﹤0.01% 2750

Other funds holding COGT

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Mutual of America Capital Management
Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
Harbor Investment Advisory
Harbor Investment Advisory Lutherville, Maryland $1.47B AUM 24.2% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

SBI Securities's COGT Position: Q3 2026 in Review

SBI Securities held its Cogent Biosciences (COGT) position steady in Q3 2026 at 1 share worth $32. The position accounts for ﹤0.01% of the portfolio, ranked #3835.

SBI Securities first reported a position in COGT in Q4 2024 and has held it in 8 quarters since. The position peaked at $1.35K in Q3 2025. 29 funds tracked by Wall St. Rank hold COGT as of Q3 2026.

  • SBI Securities held 1 share of Cogent Biosciences worth $32 as of Q3 2026.
  • SBI Securities left its Cogent Biosciences share count unchanged in Q3 2026.
  • Cogent Biosciences made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #3835 holding.
  • SBI Securities first reported a position in Cogent Biosciences in Q4 2024 and has held it in 8 quarters since.
  • SBI Securities's Cogent Biosciences position peaked at $1.35K in Q3 2025.
  • 29 funds tracked by Wall St. Rank held Cogent Biosciences as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.